Canyon West of Cascadia: Blood Thinner Monitoring Lapse - ID
Federal inspectors discovered the monitoring failure during an April inspection, finding that staff ignored their own care plan requirements to watch for complications from the anticoagulant apixaban.
The resident had been prescribed the 5-milligram tablets twice daily since December 27, 2025, following a physician's order. Blood thinners like apixaban carry serious risks, requiring careful observation for signs of internal bleeding and other potentially life-threatening complications.
The facility's care plan, initiated the same day as the prescription, specifically directed staff to monitor and document potential side effects. The plan listed warning signs staff should watch for: abnormal bleeding or bruising, black stools, pink-tinged urine, leg pain or swelling, nausea and vomiting, and sudden onset of chest pain or shortness of breath.
Staff were instructed to notify the physician if any of these symptoms appeared.
But inspectors found no documentation that anyone had been monitoring the resident for these complications. The resident's medical records contained no evidence that staff were checking for the dangerous side effects outlined in his care plan.
When confronted with the findings on April 14, the facility's chief nursing officer acknowledged the failure. At 10:15 AM that day, the CNO told inspectors the resident "did not have monitoring for his anticoagulant and there should be a monitor."
The resident had multiple health conditions that made him particularly vulnerable. He was admitted to Canyon West with diabetes and chronic obstructive pulmonary disease, both serious conditions that can complicate medication management.
Anticoagulants like apixaban are prescribed to prevent blood clots but require vigilant monitoring because they can cause severe internal bleeding. The medication works by interfering with the blood's ability to clot, making even minor injuries potentially dangerous if not detected early.
The facility's own policy, revised September 3, 2025, promised comprehensive care plans that would include "appropriate interventions" and reflect each resident's individual conditions and risks. The policy stated care plans must be developed "in accordance with professional standards of practice."
Federal regulations require nursing homes to implement the interventions specified in their care plans. The State Operations Manual explicitly states that comprehensive care plans "must reflect interventions to enable each resident to meet his/her objectives."
Canyon West's failure to follow through on its monitoring commitment created what inspectors called "potential for harm should Resident #2 experience complications and receive inappropriate or inadequate care."
The consequences of missed anticoagulant monitoring can be severe. Internal bleeding can develop gradually, with symptoms like fatigue and weakness that might be attributed to other conditions. By the time obvious signs like black stools or severe bruising appear, significant blood loss may have already occurred.
Pink-tinged urine can indicate kidney bleeding. Sudden chest pain or shortness of breath might signal a pulmonary embolism or bleeding in the lungs. Leg pain and swelling could indicate dangerous clots forming despite the medication.
Without proper monitoring, staff would have no systematic way to detect these warning signs before they became medical emergencies.
The inspection found Canyon West failed to ensure their care plan interventions were actually implemented, affecting one of 20 residents whose records were reviewed. While inspectors classified the violation as causing "minimal harm or potential for actual harm," the failure represented a breakdown in basic medication safety protocols.
The resident continued taking his twice-daily blood thinner while staff remained unaware of whether the powerful medication was causing internal bleeding or other dangerous complications that could have been caught with proper monitoring.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Canyon West of Cascadia from 2026-04-16 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
Canyon West of Cascadia in Caldwell, ID was cited for violations during a health inspection on April 16, 2026.
The resident had been prescribed the 5-milligram tablets twice daily since December 27, 2025, following a physician's order.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.